Response by Fordyce et al to Letter Regarding Article, "On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF".
Publication
, Journal Article
Fordyce, CB; Piccini, JP; Patel, MR
Published in: Circulation
November 29, 2016
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
November 29, 2016
Volume
134
Issue
22
Start / End Page
e532 / e533
Location
United States
Related Subject Headings
- Warfarin
- Treatment Outcome
- Stroke
- Rivaroxaban
- Humans
- Factor Xa Inhibitors
- Cardiovascular System & Hematology
- Atrial Fibrillation
- Anticoagulants
- 4207 Sports science and exercise
Citation
APA
Chicago
ICMJE
MLA
NLM
Fordyce, C. B., Piccini, J. P., & Patel, M. R. (2016). Response by Fordyce et al to Letter Regarding Article, "On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF". Circulation, 134(22), e532–e533. https://doi.org/10.1161/CIRCULATIONAHA.116.025258
Fordyce, Christopher B., Jonathan P. Piccini, and Manesh R. Patel. “Response by Fordyce et al to Letter Regarding Article, "On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF".” Circulation 134, no. 22 (November 29, 2016): e532–33. https://doi.org/10.1161/CIRCULATIONAHA.116.025258.
Fordyce CB, Piccini JP, Patel MR. Response by Fordyce et al to Letter Regarding Article, "On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF". Circulation. 2016 Nov 29;134(22):e532–3.
Fordyce, Christopher B., et al. “Response by Fordyce et al to Letter Regarding Article, "On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF".” Circulation, vol. 134, no. 22, Nov. 2016, pp. e532–33. Pubmed, doi:10.1161/CIRCULATIONAHA.116.025258.
Fordyce CB, Piccini JP, Patel MR. Response by Fordyce et al to Letter Regarding Article, "On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF". Circulation. 2016 Nov 29;134(22):e532–e533.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
November 29, 2016
Volume
134
Issue
22
Start / End Page
e532 / e533
Location
United States
Related Subject Headings
- Warfarin
- Treatment Outcome
- Stroke
- Rivaroxaban
- Humans
- Factor Xa Inhibitors
- Cardiovascular System & Hematology
- Atrial Fibrillation
- Anticoagulants
- 4207 Sports science and exercise